Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics in Research01:56

Ethics in Research

23.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Teaching AI ethics in medical schools: a scoping review protocol on the ethical-technical balance in curricular frameworks.

BMJ open·2026
Same author

Ethical issues in the clinical use of diagnostic technologies for rare causes of psychosis.

The British journal of psychiatry : the journal of mental science·2026
Same author

Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation.

Journal of medical Internet research·2026
Same author

Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.

Cell reports. Medicine·2026
Same author

Domain arrangement-driven immunogenicity of a computationally designed mRNA vaccine targeting PPE68, IrtA, and PE9 of Mycobacterium tuberculosis.

Scientific reports·2026
Same author

Enhancing tuberculosis vaccine efficacy with a heterologous mRNA-ChAdOx1 prime-pull strategy targeting lung-resident memory T cells.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jul 6, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.0K

Exploring the ethics of tuberculosis human challenge models.

Abie Rohrig1,2,3, Josh Morrison2, Gavriel Kleinwaks2

  • 1Columbia University, New York, New York, USA.

Journal of Medical Ethics
|December 30, 2023
PubMed
Summary

Human challenge trials for tuberculosis (TB) could speed vaccine development. Ethical considerations, including participant and third-party risks, are crucial for TB vaccine research and could save millions of lives.

Keywords:
clinical trialcommunicable diseasesethics- research

More Related Videos

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

11.9K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

19.9K

Related Experiment Videos

Last Updated: Jul 6, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.0K
Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
09:23

Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex

Published on: June 30, 2019

11.9K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

19.9K

Area of Science:

  • Medical ethics
  • Infectious disease research
  • Vaccine development

Background:

  • Human challenge trials are increasingly discussed for accelerating vaccine development.
  • Ethical concerns regarding participant and third-party risks have limited tuberculosis (TB) challenge studies.
  • TB presents unique ethical challenges due to high disease burden and lack of highly effective vaccines.

Purpose of the Study:

  • To analyze the ethical considerations and social value of human challenge trials for TB vaccine development.
  • To compare TB challenge models and identify key ethical differences from other challenge trials.
  • To assess the potential impact of TB challenge trials on vaccine availability and lives saved.

Main Methods:

  • Analysis of expected social value and risks associated with different TB challenge models.
  • Identification and evaluation of ethical considerations specific to TB, including disease burden, third-party risk, biosafety, treatment risks, and detection difficulties.
  • Review of potential challenge agents, such as attenuated strains of Bacillus Calmette-Guérin or Mycobacterium tuberculosis.

Main Results:

  • A TB challenge trial with a 10%-50% chance of earlier vaccine authorization could save 26,400 to 1,100,000 lives in 10 years.
  • Key ethical considerations differentiating TB include high disease burden, lack of effective vaccines, heightened third-party risk, stringent biosafety needs, treatment risks, and detection challenges.
  • Attenuated strains like Bacillus Calmette-Guérin or Mycobacterium tuberculosis are potential candidates for TB challenge trials.

Conclusions:

  • TB challenge trials offer significant potential social value by accelerating the development of more effective vaccines.
  • Careful consideration of unique ethical factors, including stringent biosafety measures, is essential for conducting TB challenge trials responsibly.
  • Conducting TB challenge trials with attenuated strains warrants serious consideration to advance TB vaccine research.